CDKN2B and carcinosarcoma: Meanwhile, for the CDKN2B-AS antisense lncRNA, we reviewed all three promoters and found the highest expression in carcinosarcoma cells, gastrointestinal carcinoma cells, osteosarcoma cells, lens epithelial cells and gall bladder carcinoma cells.